{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:50:13Z","timestamp":1791633013708,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009242","name":"DGOS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009243","name":"Direction G\u00e9n\u00e9rale de l\u2019offre de Soins","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cmi.2026.09.022","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:47:42Z","timestamp":1790380062000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deciphering acquired resistance to amikacin in Mycobacterium abscessus clinical isolates selected from patients with pulmonary disease treated with aminoglycoside: a 2012\u20132025 retrospective cohort study"],"prefix":"10.1016","author":[{"given":"Camille","family":"Allam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Agsous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"S\u00f8nderm\u00f8le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Baylac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"La","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Godron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeina","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corentin","family":"Poignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza","family":"Mougari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Cambau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2026.09.022_bib1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/jac\/dkr578","article-title":"Mycobacterium abscessus: A new antibiotic nightmare","volume":"67","author":"Nessar","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2026.09.022_bib2","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.cmi.2023.09.019","article-title":"Antimicrobial susceptibility of Mycobacterium abscessus and treatment of pulmonary and extra-pulmonary infections","volume":"30","author":"Tunesi","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2026.09.022_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijid.2022.10.013","article-title":"Global trends of pulmonary infections with nontuberculous mycobacteria: A systematic review","volume":"125","author":"Dahl","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2026.09.022_bib4","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cmi.2023.08.035","article-title":"Epidemiology of Mycobacterium abscessus","volume":"30","author":"Cristancho-Rojas","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2026.09.022_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: An official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2026.09.022_bib6","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1080\/14656566.2021.1953472","article-title":"The role of amikacin in the treatment of nontuberculous mycobacterial disease","volume":"22","author":"Raaijmakers","year":"2021","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.cmi.2026.09.022_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.05041-22","article-title":"Subspecies distribution and antimicrobial susceptibility testing of Mycobacterium abscessus clinical isolates in Madrid, Spain: A retrospective multicenter study","volume":"11","author":"Ruedas-L\u00f3pez","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.cmi.2026.09.022_bib8","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.2147\/IDR.S357887","article-title":"Inducible resistance to amikacin in Mycobacterium abscessus isolated in Beijing, China","volume":"15","author":"Zhang","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.cmi.2026.09.022_bib9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jgar.2019.05.016","article-title":"Detection and molecular characterisation of amikacin-resistant Mycobacterium abscessus isolated from patients with pulmonary disease","volume":"19","author":"Wu","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.cmi.2026.09.022_bib10","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.chest.2023.05.036","article-title":"Open-label trial of amikacin liposome inhalation suspension in Mycobacterium abscessus lung disease","volume":"164","author":"Siegel","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2026.09.022_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0319710","article-title":"Infection model of THP-1 cells, growth dynamics, and antimicrobial susceptibility of clinical Mycobacterium abscessus isolates from cystic fibrosis patients: Results from a multicentre study","volume":"20","author":"Ruedas-L\u00f3pez","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2026.09.022_bib12","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/jac\/dkx021","article-title":"Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria","volume":"72","author":"Mougari","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2026.09.022_bib13","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/jac\/dkr209","article-title":"Genetic analysis of new 16S rRNA mutations conferring aminoglycoside resistance in Mycobacterium abscessus","volume":"66","author":"Nessar","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2026.09.022_bib14","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/jac\/dkae468","article-title":"Correlation between rrs gene mutations and amikacin resistance in Mycobacterium abscessus: Implications for fitness cost and clinical prevalence","volume":"80","author":"Ding","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2026.09.022_bib15","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1038\/s41598-021-85721-5","article-title":"Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.cmi.2026.09.022_bib16","article-title":"A single upstream mutation of whiB7 underlies amikacin and clarithromycin resistance in Mycobacterium abscessus","volume":"135","author":"De Boeck","year":"2024","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.cmi.2026.09.022_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01347-17","article-title":"Mycobacterium abscessus WhiB7 regulates a species-specific repertoire of genes to confer extreme antibiotic resistance","volume":"61","author":"Hurst-Hess","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.09.022_bib18","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.cmi.2023.02.007","article-title":"Towards clinical breakpoints for non-tuberculous mycobacteria\u2014Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution","volume":"29","author":"Fr\u00f6berg","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2026.09.022_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac465","article-title":"Amikacin liposomal inhalation suspension in the treatment of Mycobacterium abscessus lung infection: A french observational experience","volume":"9","author":"Chiron","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2026.09.022_bib20","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2026.09.022_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.cmi.2023.06.005","article-title":"Appeal from the European Reference Laboratory Network for TB (ERLTB-Net) for improving the diagnosis of infections due to nontuberculous mycobacteria","volume":"30","author":"Tagliani","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2026.09.022_bib22","series-title":"Clinical and Laboratory Standards Institute. M24S performance standards for susceptibility testing of mycobacteria, Nocardia spp, and other aerobic actinomycetes","author":"Parrish","year":"2018"},{"key":"10.1016\/j.cmi.2026.09.022_bib23","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1086\/515328","article-title":"A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae","volume":"177","author":"Prammananan","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2026.09.022_bib24","article-title":"Limited predictive power of known resistance genes for phenotypic drug resistance in clinical Mycobacterium abscessus complex from Beijing in China","volume":"69","author":"Hou","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.09.022_bib25","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1038\/s41467-024-46552-w","article-title":"Microevolution, reinfection and highly complex genomic diversity in patients with sequential isolates of Mycobacterium abscessus","volume":"15","author":"Buenestado-Serrano","year":"2024","journal-title":"Nat Commun"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26005380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26005380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:33:29Z","timestamp":1791632009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X26005380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":25,"alternative-id":["S1198743X26005380"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.09.022","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering acquired resistance to amikacin in Mycobacterium abscessus clinical isolates selected from patients with pulmonary disease treated with aminoglycoside: a 2012\u20132025 retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}